Showing results (161-170 of 319) with videos related to
Sort By:
Pageof 32
Journal of Neurology|April 27, 2023
Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extensionAndreas Meisel, Djillali Annane, Tuan Vu, et al.BMC Neurology|December 25, 2015
Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot studySarah Hoffmann, Jana Siedler, Alexander U Brandt, et al.Neuromuscular Disorders : NMD|February 6, 2023
Autoantibody detection by a live cell-based assay in conventionally antibody-tested triple seronegative Myasthenia gravisSarah Hoffmann, Patrick Waters, Leslie Jacobson, et al.Stroke|July 17, 2012
Development of a clinical score (A2DS2) to predict pneumonia in acute ischemic strokeSarah Hoffmann, Uwe Malzahn, Hendrik Harms, et al.Frontiers in Immunology|April 23, 2025
The burden of disease in seronegative myasthenia gravis: a patient-centered perspectiveSophie Lehnerer, Regina Stegherr, Ulrike Grittner, et al.Journal of Autoimmunity|April 18, 2026
Impact of a ketogenic diet on clinical outcomes and immunological markers in myasthenia gravis: A randomized pilot studyBenjamin Makus, Daniel Schulze, Sophie Lehnerer, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 22, 2015
Blocking stroke-induced immunodeficiency increases CNS antigen-specific autoreactivity but does not worsen functional outcome after experimental strokeChristine Römer, Odilo Engel, Katarzyna Winek, et al.Brain Communications|September 21, 2020
Bortezomib at therapeutic doses poorly passes the blood-brain barrier and does not impair cognitionPetra Huehnchen, Andreas Springer, Johannes Kern, et al.Journal of Neurology|November 20, 2021
Burden of disease in myasthenia gravis: taking the patient's perspectiveSophie Lehnerer, Jonas Jacobi, Ralph Schilling, et al.Journal of Neurology|August 28, 2013
Seroprevalence of anti-N-methyl-D-aspartate receptor antibodies in women with ovarian teratomaMandy Mangler, Isabel Trebesch de Perez, Bianca Teegen, et al.Pageof 32